Neurogenic inflammation as a pathway distinct firom iven, immuine-meited infla n m pl a piol lei understadn a broad cssof eniomn- 234-238(1993) Sensitivity to environmental chemicals in general, and in particular to volatile organic chemicals (VOCs) in indoor air, needs to be elucidated. The lack of an established mechanism to explain how exposure to concentrations of VOCs that are well tolerated by the population at large can produce the array of symptoms seen in sensitized individuals has hampered progress in understanding these disorders. Over (3) (4) (5) (6) . Direct stimulation of sensory nerves produces vasodilatation (7, 8) , which can be blocked by depletion of substance P with capsaicin (9-11). The sensory fibers involved in neurogenic inflammation have been identified as C-fibers with a slow velocity of 1-2 m/sec (14. Progress has been made in understanding the regulation of neurogenic inflammation (13) . A cell-surface enzyme, neutral endopeptidase (NEP), downregulates neurogenic inflammation by degradating substance P. In the lung this enzyme is inhibited by cigarette smoke, viral infections, and toluene diisocynate, whereas corticosteroids increase NEP.
Neurogenic inflammation is now a well-defined physiological mechanism by which mediators are directly released from sensory nerves to produce-vasodilatation, edema, and other manifestations of inflammation. The nerve fibers have been identified as slow velocity C-fibers, and the regulation of neurogenic inflammation has been studied.
Chemical Irritant Receptors
The common chemical sense is a nasal sensation provoked by airborne chemicals which is distinct from taste and smell (14) . This sense is experienced as a burning and painfil sensation in the upper airways and eyes upon exposure to irritant (22) (23) (24) (25) , and the volatile organic chemical toluene diisocyanate (26) . It is now known that the neuropeptides of neurogenic inflammation reproduce the pathology of asthma (27) , and the role of neurogenic inflammation has been documented in animal models of asthma (28) . Barnes (29) 
Another disorder that increased significantly during the 1980s is migraine headaches (36) . Headache is an early and consistent consequence of exposure to VOCs. On the basis of pharmaceutical responses of migraine and animal experiments, Nicolodi and Sicuteri proposed that neurogenic inflammation plays a role in the pathophysiology of migraine headaches (37) . Silberstein argued that both tension headaches and migraine may be generated by neurogenic inflammation (38) . Buzzi and Moskowitz demonstrated that stimulation of trigeminal sensory fibers leads to changes consistent with those of migraine in a rat model, and these changes can be blocked by the antimigraine drugs sumatriptan and dihydroergotamine (39) . Hardebo has pointed out that the postulate that neurogenic inflammation mediates migraine provides a rational explanation for why serotonin antagonists are effective in treating migraine (40) . Challenge (44.45) , it re-mains highly controversial.
Reactive airways dysfunction syndrome (RADS) is an asthmalike illness that develops within minutes to hours after an acute exposure to dust, smoke, or solvent. There is persistent bronchial hyperreactivity with positive methacholine challenge. The asthma becomes chronic after the initial exposure and can be difficult to treat (46) . Reactive upper-airways dysfunction syndrome (RUDS) also follows a chemical exposure, and there is persistent chronic rhinitis. The chief complaint of patients with RUDS is chemical sensitivity (47) . Unlike patients with RADS, medical attention is not sought on the day of exposure, which probably reflects the fact that breathing is compromised in RADS but not in RUDS. Preliminary study of the nasal mucosa found lymphocytic infiltrates, and electron microscopy has shown thickening of the basement membrane and desquamation of the respiratory epithelium (48) .
There are many similarities between SBS, MCS, RADS, and RUDS (Fig. 3) . In each snydrome, a high-dose exposure induces the syndrome, and subsequent exacerbations are associated with low-level exposures. SBS and MCS include symptoms involving more than one organ system, with the respiratory mucosal and central nervous system being prominently involved. The major difference between SBS and MCS is that SBS refers to a cluster of cases associated with a building, while MCS patients have more generalized complaints. RADS and RUDS have prominent airway involvement, with the difference between the two being that RADS involves the lower airway (asthma), and RUDS involves the upper airway (rhinitis). In one small series, 100% of patients with RUDS had extra-airway manifestations and met the Cullen case definition (49) for MCS.
These syndromes may be related at a deeper level. All of these illnesses may be disorders of the regulation of neurogenic inflammation. The inducing exposure may alter the respiratory mucosa in one or more ways. The regulation of neurogenic inflammation may be disturbed by the depletion of NEP or other enzymes, which would result in a heightened response to subsequent exposures. The desquamation of the respiratory epithelium seen in RUDS may remove a barrier to chemical irritants, so that chemical irritants may reach and trigger the irritant receptors at lower concentrations.
Patients with these illnesses complain of symptoms in organ systems in addition to the airways, and some patients have no airways symptoms at all. Mechanisms to explain how airway irritants can trigger systemic symptoms must be considered. First, it is common for inflammatory illnesses primarily arising in one organ or tissue to produce systemic manifestations (e.g., the extra-articular manifestations of rheumatoid arthritis and the systemic manifestations of Crohn's disease). Viral Both the mediators and regulators of inflammation may be released from the site of inflammation and affect distant sites. Two important regulators of inflammation, interleukin 1 and interleukin 2, suppress central nervous system activity (50, 51) . Another possibility is that some form of neural switching may take place. That is, triggering of chemical irritant receptors in one organ could lead to an efferent signal traveling to another site through an aberrant or conditioned crossing of the pathways. A combination of these two mechanisms may be operative.
The hypothesis that neurogenic inflammation is the mechanism of chemical sensitivity syndromes is amenable to scientific study. Biopsies of the airways of chemically sensitive individuals should be abnormal, with signs of inflammation. Immunofluorescent monoclonal antibodies could be used to detect NEP, which should be decreased, and substance P, which should be elevated relative to controls. Nasal washings should contain increased levels of the mediators of neurogenic inflammation relative to controls, and the levels should increase after chemical challenge in 
